135 related articles for article (PubMed ID: 2382254)
1. Local activation of the coagulation and fibrinolysis systems in lung disease.
Nakstad B; Lyberg T; Skjønsberg OH; Boye NP
Thromb Res; 1990 Mar; 57(6):827-38. PubMed ID: 2382254
[TBL] [Abstract][Full Text] [Related]
2. [Coagulation and fibrinolysis systems in bronchoalveolar lavage fluid in irradiated lung of rabbits].
Sawada M
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1515-21. PubMed ID: 8121087
[TBL] [Abstract][Full Text] [Related]
3. Local abnormalities of coagulation and fibrinolysis and alveolar fibrin deposition in sheep with oleic acid-induced lung injury.
Idell S; Peterson BT; Gonzalez KK; Gray LD; Bach R; McLarty J; Fair DS
Am Rev Respir Dis; 1988 Nov; 138(5):1282-94. PubMed ID: 3202484
[TBL] [Abstract][Full Text] [Related]
4. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.
Idell S; James KK; Levin EG; Schwartz BS; Manchanda N; Maunder RJ; Martin TR; McLarty J; Fair DS
J Clin Invest; 1989 Aug; 84(2):695-705. PubMed ID: 2788176
[TBL] [Abstract][Full Text] [Related]
5. Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis.
Hasday JD; Bachwich PR; Lynch JP; Sitrin RG
Exp Lung Res; 1988; 14(2):261-78. PubMed ID: 3371278
[TBL] [Abstract][Full Text] [Related]
6. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease.
Günther A; Mosavi P; Ruppert C; Heinemann S; Temmesfeld B; Velcovsky HG; Morr H; Grimminger F; Walmrath D; Seeger W
Thromb Haemost; 2000 Jun; 83(6):853-60. PubMed ID: 10896238
[TBL] [Abstract][Full Text] [Related]
7. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis.
Kotani I; Sato A; Hayakawa H; Urano T; Takada Y; Takada A
Thromb Res; 1995 Mar; 77(6):493-504. PubMed ID: 7624837
[TBL] [Abstract][Full Text] [Related]
8. Fibrinopeptide A reactive peptides and procoagulant activity in bronchoalveolar lavage: relationship to rheumatoid interstitial lung disease.
Idell S; Garcia JG; Gonzalez K; McLarty J; Fair DS
J Rheumatol; 1989 May; 16(5):592-8. PubMed ID: 2666653
[TBL] [Abstract][Full Text] [Related]
9. Salmeterol enhances pulmonary fibrinolysis in healthy volunteers.
Maris NA; de Vos AF; Bresser P; van der Zee JS; Jansen HM; Levi M; van der Poll T
Crit Care Med; 2007 Jan; 35(1):57-63. PubMed ID: 17080003
[TBL] [Abstract][Full Text] [Related]
10. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition.
Idell S; James KK; Gillies C; Fair DS; Thrall RS
Am J Pathol; 1989 Aug; 135(2):387-99. PubMed ID: 2476934
[TBL] [Abstract][Full Text] [Related]
12. Tissue fibrin deposition during acute lung injury in rabbits and its relationship to local expression of procoagulant and fibrinolytic activities.
Sitrin RG; Brubaker PG; Fantone JC
Am Rev Respir Dis; 1987 Apr; 135(4):930-6. PubMed ID: 3565941
[TBL] [Abstract][Full Text] [Related]
13. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.
Eisenberg PR; Lucore C; Kaufman L; Sobel BE; Jaffe AS; Rich S
Circulation; 1990 Sep; 82(3):841-7. PubMed ID: 2394005
[TBL] [Abstract][Full Text] [Related]
14. Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII.
Idell S; Gonzalez K; Bradford H; MacArthur CK; Fein AM; Maunder RJ; Garcia JG; Griffith DE; Weiland J; Martin TR
Am Rev Respir Dis; 1987 Dec; 136(6):1466-74. PubMed ID: 3688650
[TBL] [Abstract][Full Text] [Related]
15. Thrombosis and intrinsic fibrinolysis in percutaneous transluminal angioplasty.
Jørgensen B; Nielsen JD; Helligsø P; Baekgaard N; Egeblad M
Eur J Vasc Surg; 1994 May; 8(3):264-9. PubMed ID: 8013675
[TBL] [Abstract][Full Text] [Related]
16. Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome.
Viscardi RM; Broderick K; Sun CC; Yale-Loehr AJ; Hessamfar A; Taciak V; Burke KC; Koenig KB; Idell S
Am Rev Respir Dis; 1992 Aug; 146(2):492-9. PubMed ID: 1489146
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of coagulation, fibrinolytic and antifibrinolytic markers in adenocarcinoma of the lung.
Nakstad B; Lyberg T
APMIS; 1991 Nov; 99(11):981-8. PubMed ID: 1720319
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolytic activity in bronchoalveolar lavage of baboons with diffuse alveolar damage: trends in two forms of lung injury.
Idell S; James KK; Coalson JJ
Crit Care Med; 1992 Oct; 20(10):1431-40. PubMed ID: 1395665
[TBL] [Abstract][Full Text] [Related]
19. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome.
Günther A; Mosavi P; Heinemann S; Ruppert C; Muth H; Markart P; Grimminger F; Walmrath D; Temmesfeld-Wollbrück B; Seeger W
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):454-62. PubMed ID: 10673185
[TBL] [Abstract][Full Text] [Related]
20. Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage.
Idell S; Peters J; James KK; Fair DS; Coalson JJ
J Clin Invest; 1989 Jul; 84(1):181-93. PubMed ID: 2738151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
